Sign In
Buy MYO
$1.00
+0.0699 (+7.52%)
At Close: Jul 30, 2026
Top 3 Cutting-Edge Micro-Caps Set for 2025 Growth
07:47am, Tuesday, 17'th Dec 2024
As 2025 approaches, several promising micro-cap stocks are gaining attention for their potential to disrupt key industries. These companies, though small in market size, are making significant strides
Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock
07:30am, Thursday, 05'th Dec 2024
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upp
Myomo, Inc. Announces Proposed Public Offering of Common Stock
04:05pm, Wednesday, 04'th Dec 2024
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upp
Myomo, Inc. (MYO) Q3 2024 Earnings Call Transcript
10:11pm, Wednesday, 06'th Nov 2024
Myomo, Inc. (MYO) Q3 2024 Earnings Call Transcript
Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates
07:00pm, Wednesday, 06'th Nov 2024
Myomo, Inc. (MYO) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.06 per share a year ago.
CMS Decision And O&P Network Build Out Make Myomo A Buy
03:30pm, Tuesday, 05'th Nov 2024
Myomo's business model is now sustainable due to CMS reclassifying MyoPro, leading to lump sum payments and consistent insurance coverage. Medicare Part B coverage has significantly improved Myomo's o
Myomo to Report Third Quarter Financial Results on November 6, 2024
04:05pm, Wednesday, 30'th Oct 2024
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi
Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit
04:05pm, Wednesday, 09'th Oct 2024
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi
Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly
08:30am, Thursday, 12'th Sep 2024
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi
Myomo to Participate in Two Investor Conferences in September
04:15pm, Thursday, 05'th Sep 2024
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi
Myomo, Inc. (MYO) Q2 2024 Earnings Call Transcript
11:03am, Friday, 09'th Aug 2024
Myomo, Inc. (NYSE:MYO ) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Kim Golodetz - LHA Investor Relations Paul Gudonis - Chief Executive Officer Dave Henry - Chief
Myomo Reports Second Quarter 2024 Financial Results
04:05pm, Tuesday, 06'th Aug 2024
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi
Myomo to Present at the Sidoti Virtual Investor Conference on June 12-13, 2024
05:58pm, Wednesday, 05'th Jun 2024
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi
Myomo, Inc. (MYO) Q1 2024 Earnings Call Transcript
10:03pm, Wednesday, 08'th May 2024
Myomo, Inc. (NYSE:MYO ) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Kim Golodetz - LHA Investor Relations Paul Gudonis - Chief Executive Officer Dave Henry - Chief Fin
Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees
08:30am, Monday, 06'th May 2024
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi
